Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18


Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population.

Faye C, Mcgowan JC, Denny CA, David DJ.

Curr Neuropharmacol. 2018 Mar 5;16(3):234-270. doi: 10.2174/1570159X15666170818095105.


Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Harshaw C.

Psychol Bull. 2015 Mar;141(2):311-63. doi: 10.1037/a0038101. Epub 2014 Nov 3. Review.


Abnormal activation of the occipital lobes during emotion picture processing in major depressive disorder patients.

Li J, Xu C, Cao X, Gao Q, Wang Y, Wang Y, Peng J, Zhang K.

Neural Regen Res. 2013 Jun 25;8(18):1693-701. doi: 10.3969/j.issn.1673-5374.2013.18.007.


Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.

Soloff PH, Chiappetta L, Mason NS, Becker C, Price JC.

Psychiatry Res. 2014 Jun 30;222(3):140-8. doi: 10.1016/j.pscychresns.2014.03.008. Epub 2014 Mar 29.


Positron emission tomography molecular imaging in late-life depression.

Hirao K, Smith GS.

J Geriatr Psychiatry Neurol. 2014 Mar;27(1):13-23. doi: 10.1177/0891988713516540. Epub 2014 Jan 5. Review.


Genes in the serotonin pathway are associated with bipolar affective disorder in a Han Chinese population.

Xiang B, Yang Z, Lin Y, Guan L, Li X, Deng W, Jiang Z, Lao G, Wang Q, Hao X, Liu X, Wang Y, Zhao L, Ma X, Li T, Cao L, Hu X.

Neurosci Bull. 2014 Feb;30(1):33-42. doi: 10.1007/s12264-013-1380-5. Epub 2013 Oct 17.


Metabolic activity in the insular cortex and hypothalamus predicts hot flashes: an FDG-PET study.

Joffe H, Deckersbach T, Lin NU, Makris N, Skaar TC, Rauch SL, Dougherty DD, Hall JE.

J Clin Endocrinol Metab. 2012 Sep;97(9):3207-15. doi: 10.1210/jc.2012-1413. Epub 2012 Jun 20.


Low brain serotonin transporter binding in major depressive disorder.

Newberg AB, Amsterdam JD, Wintering N, Shults J.

Psychiatry Res. 2012 May 31;202(2):161-7. doi: 10.1016/j.pscychresns.2011.12.015. Epub 2012 Jun 12.


Brain aging research at the close of the 20th century: from bench to bedside.

Cidis Meltzer C, Francis PT.

Dialogues Clin Neurosci. 2001 Sep;3(3):167-80.


Functional neuroimaging in geriatric depression.

Gunning FM, Smith GS.

Psychiatr Clin North Am. 2011 Jun;34(2):403-22, viii. doi: 10.1016/j.psc.2011.02.010. Epub 2011 Apr 8. Review.


Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain.

Wang H, Ahrens C, Rief W, Gantz S, Schiltenwolf M, Richter W.

Arthritis Res Ther. 2010;12(5):R186. doi: 10.1186/ar3156. Epub 2010 Oct 11.


Influence of comorbidity with depression on interdisciplinary therapy: outcomes in patients with chronic low back pain.

Wang H, Ahrens C, Rief W, Schiltenwolf M.

Arthritis Res Ther. 2010;12(5):R185. doi: 10.1186/ar3155. Epub 2010 Oct 11.


Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.

Frokjaer VG, Vinberg M, Erritzoe D, Baaré W, Holst KK, Mortensen EL, Arfan H, Madsen J, Jernigan TL, Kessing LV, Knudsen GM.

Neuropsychopharmacology. 2010 Apr;35(5):1129-37. doi: 10.1038/npp.2009.218. Epub 2009 Dec 30.


Gender, personality, and serotonin-2A receptor binding in healthy subjects.

Soloff PH, Price JC, Mason NS, Becker C, Meltzer CC.

Psychiatry Res. 2010 Jan 30;181(1):77-84. doi: 10.1016/j.pscychresns.2009.08.007.


Genetic variation in the serotonin 2A receptor and suicidal ideation in a sample of 270 Irish high-density schizophrenia families.

Fanous AH, Chen X, Wang X, Amdur R, O'Neill FA, Walsh D, Kendler KS.

Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):411-7. doi: 10.1002/ajmg.b.30833.


Future prospects in depression research.

Holtzheimer PE 3rd, Nemeroff CB.

Dialogues Clin Neurosci. 2006;8(2):175-89. Review.


Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.

Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, McConaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH.

Neuropsychopharmacology. 2004 Jun;29(6):1143-55.

Supplemental Content

Support Center